Atlas Trials

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease

Clinical trial NCT05267743 · COMPLETED

Trial details

NCT number
NCT05267743
Sponsor
HK inno.N Corporation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Erosive Reflux Disease
Start date
2021-02-16
Primary completion
2022-05-25
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.